BIOBIDE

Biobide, Your Zebrafish Partner

@biobide

San Sebastián, Gipuzkoa
http://www.biobide.com
Biotechnology Research

Overview

About Biobide, Your Zebrafish Partner

Contract Research Organization with offices in San Sebastian (Spain) and Cambridge (USA) offering more than 15 years of experience Zebrafish Services to Pharmaceutical, Biotech, Chemical, Cosmetic, and Nutraceutical companies.

Our main aim is to accelerate our Clients R&D process minimizing risks through the zebrafish animal model, adding value to clients R&D&i mainly in preclinical toxicology, efficacy and disease models development. We are specialized in zebrafish working under Good Laboratory Practice (GLP) and thanks to our automated and innovative tools, we have developed and validated several fast and cost-effective Toxicity and Efficacy Assays, as well as disease models generation to be used in the preclinical stages.

We are experts developing Tailor Made Solutions based on Client's requirements, such as models generation in different therapeutic areas, validation of diverse targets as well as customization of implemented assays.

Biobide's Pipeline:

- TARGET VALIDATION (with morpholinos)

- DISEASE MODELS GENERATION

- TOXICITY ASSAYS: Acutetox Assay, Teratox Assay, Cardiotox Assay, Hepatotox Assay, Behaviour Alteration's Assay, Ototox Assay, Immunotox Assay and Ecotox Assays

- EFFICACY ASSAYS: Oncology (angiogenesis inhibition, tumoral models...), Central Nervous System (Alzheimer's Disease, Parkinson's Disease, Epilepsy, Neuroprotection...), Cardiovascular & Metabolism, Rare Diseases, Infectious Diseases...

- TAILOR-MADE SOLUTIONS

----------

· Follow us on Twitter: https://twitter.com/biobide_
· "Like" our Facebook page: https://www.facebook.com/Biobide-1286387971453667/

Headquarters

San Sebastián, Gipuzkoa

Website

http://www.biobide.com

Company Size

11-50 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

2025

Specialties

Tailor Made Solutions, Toxicity Assays, Efficacy Assays, Automated High Content Screening, Ecotoxicity, Fee for Service, Drug Discovery, Zebrafish, Disease Models Generation, Teratogenicity, Cardiotoxicity, Behaviour studies, Hepatotoxicity, and Acute toxicity

Posts